Renin inhibition mitigates anti-angiogenesis in spontaneously hypertensive rats

Journal of Hypertension

Volumn 29, Issue 2, 2011, Pages 266-272

  Rusai, Krisztina ^b   Jianxing, Chang ^b   Schneider, Ruth ^b   Struijker Boudier, Harry ^b   Lutz, Jens ^b   Heemann, Uwe ^b   Baumann, Marcus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

aliskiren; angiopoietin; anti angiogenesis; prehypertensive treatment; spontaneously hypertensive rats

Indexed keywords

ALISKIREN; ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; N(G) NITROARGININE METHYL ESTER; PLACEBO; PROTEIN KINASE B; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CAPILLARY DENSITY; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; HEART VENTRICLE HYPERTROPHY; HOMEOSTASIS; MEAN ARTERIAL PRESSURE; NONHUMAN; PREHYPERTENSION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

EID: 78651329536     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328340aa72     Document Type: Article

References (31)

1. Gasser P, Buhler FR. Nailfold microcirculation in normotensive and essential hypertensive subjects, as assessed by video-microscopy. J Hypertens 1992; 10:83-86.
2. Olzinski AR, McCafferty TA, Zhao SQ, Behm DJ, Eybye ME, Maniscalco K, et al. Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection. Cardiovasc Res 2005; 66:170-178.
3. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 2006; 12:235-239.
4. Lowenstein CJ, Morrell CN, Yamakuchi M. Regulation of Weibel-Palade body exocytosis. Trends Cardiovasc Med 2005; 15:302-308.
5. Rondaij MG, Bierings R, Kragt A, van Mourik JA, Voorberg J. Dynamics and plasticity of Weibel-Palade bodies in endothelial cells. Arterioscler Thromb Vasc Biol 2006; 26:1002-1007.
6. You D, Cochain C, Loinard C, Vilar J, Mees B, Duriez M, et al. Hypertension impairs postnatal vasculogenesis: role of antihypertensive agents. Hypertension 2008; 51:1537-1544.
7. Debbabi H, Uzan L, Mourad JJ, Safar M, Levy BI, Tibirica E. Increased skin capillary density in treated essential hypertensive patients. Am J Hypertens 2006; 19:477-483.
8. Otani A, Takagi H, Oh H, Koyama S, Honda Y. Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells. Diabetes 2001; 50:867-875.
9. Baumann M, Hermans JJ, Janssen BJ, Peutz-Kootstra C, Witzke O, Heemann U, et al. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of spironolactone and losartan regarding long-term blood pressure and target organ damage. J Hypertens 2007; 25:2504-2511.
10. Baumann M, Janssen BJ, Hermans JR, Peutz-Kootstra C, Witzke O, Smits JF, Struijker Boudier HA. Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age. J Hypertens 2007; 25:207-215.
11. Baumann M, Megens R, Bartholome R, Dolff S, van Zandvoort MA, Smits JF, et al. Prehypertensive renin-angiotensin-aldosterone system blockade in spontaneously hypertensive rats ameliorates the loss of long-term vascular function. Hypertens Res 2007; 30:853-861.
12. Ishiguro K, Sasamura H, Sakamaki Y, Itoh H, Saruta T. Developmental activity of the renin-angiotensin system during the 'critical period' modulates later L-NAME-induced hypertension and renal injury. Hypertens Res 2007; 30:63-75.
13. Schellings MW, Baumann M, van Leeuwen RE, Duisters RF, Janssen SH, Schroen B, et al. Imatinib attenuates end-organ damage in hypertensive homozygous TGR(mRen2)27 rats. Hypertension 2006; 47:467-474.
14. Rakusan K, Cicutti N, Kazda S, Turek Z. Effect of nifedipine on coronary capillary geometry in normotensive and hypertensive rats. Hypertension 1994; 24:205-211.
15. Vilar J, Waeckel L, Bonnin P, Cochain C, Loinard C, Duriez M, et al. Chronic hypoxia-induced angiogenesis normalizes blood pressure in spontaneously hypertensive rats. Circ Res 2008; 103:761-769.
16. Fukuhara S, Sako K, Minami T, Noda K, Kim HZ, Kodama T, et al. Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol 2008; 10:513-526.
17. Struijker Boudier HA, le Noble JL, Messing MW, Huijberts MS, Le Noble FA, van Essen H. The microcirculation and hypertension. J Hypertens 1992; 10 (Suppl):S147-S156.
18. Lee JS, Song SH, Kim JM, Shin IS, Kim KL, Suh YL, et al. Angiopoietin-1 prevents hypertension and target organ damage through its interaction with endothelial Tie2 receptor. Cardiovasc Res 2008; 78:572-580.
19. Patel JV, Lim HS, Varughese GI, Hughes EA, Lip GY. Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension. Ann Med 2008; 40:215-222.
20. Ebrahimian TG, Tamarat R, Clergue M, Duriez M, Levy BI, Silvestre JS. Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice. Arterioscler Thromb Vasc Biol 2005; 25:65-70.
21. Takeshita S, Tomiyama H, Yokoyama N, Kawamura Y, Furukawa T, Ishigai Y, et al. Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats. Cardiovasc Res 2001; 52:314-320.
22. Splenser AE, Fisher ND, Danser AH, Hollenberg NK. Renal plasma flow: glomerular filtration rate relationships in man during direct renin inhibition with aliskiren. J Am Soc Hypertens 2009; 3:315-320.
23. Ge X, Low B, Liang M, Fu J. Angiotensin II directly triggers endothelial exocytosis via protein kinase C-dependent protein kinase D2 activation. J Pharmacol Sci 2007; 105:168-176.
24. Schefe JH, Neumann C, Goebel M, Danser J, Kirsch S, Gust R, et al. Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren. J Hypertens 2008; 26:1787-1794.
25. Danser AH, van den Dorpel MA, Deinum J, Derkx FH, Franken AA, Peperkamp E, et al. Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J Clin Endocrinol Metab 1989; 68:160-167.
26. Girardot D, Jover B, Moles JP, Deblois D, Moreau P. Chronic nitric oxide synthase inhibition prevents new coronary capillary generation. J Cardiovasc Pharmacol 2004; 44:322-328.
27. Babaei S, Teichert-Kuliszewska K, Zhang Q, Jones N, Dumont DJ, Stewart DJ. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. Am J Pathol 2003; 162:1927-1936.
28. Scharpfenecker M, Fiedler U, Reiss Y, Augustin HG. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci 2005; 118 (Pt 4):771-780.
29. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277:55-60.
30. De Gennaro Colonna V, Fioretti S, Rigamonti A, Bonomo S, Manfredi B, Muller EE, et al. Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism. J Hypertens 2006; 24:95-102.
31. De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, et al. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. Eur J Pharmacol 2005; 516:253-259.